OXCT1 Enhances Gemcitabine Resistance Through NF-κB Pathway in Pancreatic Ductal Adenocarcinoma

por Jinsheng Ding, Jinsheng Ding, Jinsheng Ding, Hui Li, Hui Li, Yang Liu, Yang Liu, Yongjie Xie, Yongjie Xie, Jie Yu, Huizhi Sun, Huizhi Sun, Di Xiao, Yizhang Zhou, Li Bao, Hongwei Wang, Chuntao Gao
Publicado 2021